BioSpace News Archive

Drug Development

Neurotech Initiates A Phase II Clinical Trial Of NT-501 For The Treatment Of Dry Age Related Macular Degeneration

January 5, 2006
·
2 min read
Deals

AVEO Pharmaceuticals, Inc. Acquires Rights To Novel Anti-Cancer Compound From Mitsubishi Pharma Corporation

January 5, 2006
·
4 min read
Business

Cara Therapeutics, Inc. Announces Global Licensing Deal Of Novel Pain Drug Candidate With ALZA Corporation

January 5, 2006
·
3 min read
Drug Development

Isotechnika Inc. Enrolls First Patient In Phase IIb Kidney Transplant Trial

January 5, 2006
·
4 min read
Angiotech Pharmaceuticals Initiates Anti-Infective CVC U.S. Pivotal Study

January 5, 2006
·
7 min read
Business

MacroChem Corporation Announces Reverse Stock Split And Appointment Of Two New Directors

January 5, 2006
·
3 min read
Drug Development

ZymoGenetics To Highlight Development Programs And Discuss Preliminary Findings From TACI-Ig Phase 1b Clinical Trial In RA At Upcoming Investor Conference

January 5, 2006
·
2 min read
Drug Development

Forest Laboratories, Inc. And Cypress Bioscience Inc. To Commence Third Milnacipran Phase III Trial

January 5, 2006
·
5 min read
Drug Development

XenoPort, Inc. Announces Results Of Second Phase 1 Trial For XP19986 And Describes Plans For Phase 3 Clinical Program For XP13512 As A Treatment For Restless Legs Syndrome

January 5, 2006
·
11 min read
Business

Boston Scientific Corporation Announces CEO Jim Tobin To Extend Tenure At Company

January 5, 2006
·
3 min read